@joeycav11 : Takeover offer at 10 bucks? I assume you meant $10 AUD, not USD
Not bad, but considering there has never been a company like Mesoblast in terms of bringing therapies without side effects to blockbusters like CHF, Low Back Pain, RA, Diabetic Nephropathy, etc. $10 AUD/share is bottom fishing.
Johnson & Johnson recently paid $30 billion to acquire Actelion. Not saying MESO will get that amount. Could be higher or lower (who knows? if SI even considers a buyout).
https://www.jnj.com/media-center/press-releases/johnson-johnson-to-acquire-actelion
If there is one person I would not bet against nor undervalue it is Dr. Silviu Itescu both in science smarts and business smarts. He is a baaaaaad dude.
I am expecting accelerated approvals and see blue skies ahead.
PS: Alfalfa is just that.....grass for cattle feed.
Volume quite high today, and the Powers capped the rally, page-2
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |